Professor Charles E. Geyer: Neoadjuvant therapy is becoming standard of care for HER2+ breast cancer

Charles E. Geyer

Research output: Contribution to journalEditorial

1 Scopus citations
Original languageEnglish (US)
JournalChinese Clinical Oncology
Volume5
Issue number5
DOIs
StatePublished - 2016

ASJC Scopus subject areas

  • Oncology

Cite this